Bio-Path Holdings, Inc. short interest in 2020
In 2020, Bio-Path Holdings, Inc.'s disclosed short interest ran from 4.58% of shares outstanding on 15 Jan 2020 to 5.57% on 31 Dec 2020, a change of +0.99 percentage points. The year's high was 5.88% on 15 Dec 2020 and its low 0.14% on 15 Oct 2020, averaging 1.80% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 1.79 days on 31 Dec 2020. Full history: Bio-Path Holdings, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024
2020 in figures
- Start of year
- 4.58% (15 Jan 2020)
- End of year
- 5.57% (31 Dec 2020)
- Change
- +0.99 pp
- High
- 5.88% (15 Dec 2020)
- Low
- 0.14% (15 Oct 2020)
- Average
- 1.80%
- Highest days to cover
- 1.79 (31 Dec 2020)
- SEC filings marked
- 8
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 4.58% | 1.00 | |
| 28 Feb 2020 | 1.65% | 1.00 | |
| 13 Mar 2020 | 1.55% | 1.00 | 10-K filed, results (8-K) |
| 31 Mar 2020 | 1.27% | 1.00 | |
| 15 Apr 2020 | 0.52% | 1.00 | |
| 30 Apr 2020 | 0.31% | 1.00 | |
| 15 May 2020 | 0.51% | 1.00 | 10-Q filed, results (8-K) |
| 29 May 2020 | 0.25% | 1.00 | |
| 15 Jun 2020 | 0.25% | 1.00 | |
| 30 Jun 2020 | 0.42% | 1.00 | |
| 15 Jul 2020 | 0.26% | 1.00 | |
| 31 Jul 2020 | 0.22% | 1.00 | |
| 14 Aug 2020 | 0.25% | 1.00 | 10-Q filed, results (8-K) |
| 30 Sep 2020 | 0.29% | 1.00 | |
| 15 Oct 2020 | 0.14% | 1.00 | |
| 13 Nov 2020 | 4.98% | 1.06 | 10-Q filed, results (8-K) |
| 30 Nov 2020 | 5.32% | 1.04 | |
| 15 Dec 2020 | 5.88% | 1.00 | |
| 31 Dec 2020 | 5.57% | 1.79 |
See also: Bio-Path Holdings, Inc.'s full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.